| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |